
(AGENPARL) – SILVER SPRING mar 30 maggio 2023 NEXVIAZYME is an enzyme used for the treatment of patients 1 year of age and older with late-onset Pompe disease (LOPD).
Fonte/Source: http://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshot-nexviazyme